OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Endocrinology is 60. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Exposing skin to ultraviolet irradiation increases food intake in male individuals	587
Non-nutritive sweeteners — too sweet to be wholesome?	550
Dexamethasone in patients with diabetes mellitus	510
Exercise-induced plasma factors confer brain benefits	500
CNOT6L regulates hepatokine expression	341
The role of DNA damage in diabetic complications	335
Immune cell population prevents weight regain	328
Memory of obesity stored in adipocytes	328
Identification of genetic factors of type 2 diabetes mellitus risk in South Asian populations	304
Author Correction: Adrenocortical stem cells in health and disease	298
Effects of diet on atherosclerotic plaque development	283
Timed high-fat diet feeding restores small bowel circadian rhythms	275
Limiting the use and misuse of liothyronine in hypothyroidism	219
The gut microbiota in obesity and weight management: microbes as friends or foe?	212
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead	166
The challenges of assessing adiposity in a clinical setting	166
Thyroid function and iodine intake: global recommendations and relevant dietary trends	163
Type 2 diabetes mellitus in older adults: clinical considerations and management	160
To fast or not to fast — that is the question	156
Metformin reduces ageing adipose senescence	146
Negative regulator of GDF15 signalling identified	137
Iron in adipocytes — a role in gut–adipose crosstalk	133
Ketosis improves muscle stem cell resilience	130
Obesity phenotypes: explaining the unexplained	127
Metabolite levels during the menstrual cycle	127

The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects	122
Reply to ‘Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines’	120
Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines	119
Research in metabolic ageing — a tale of mice versus humans?	117
The importance of human brown adipose tissue volume	116
A pivotal year for NAFLD and NASH therapeutics	116
Role for exosomes in insulin sensitivity	111
Neurons in the diagonal band of Broca moderate food intake	111
Patients’ insights into diabetes insipidus	106
Handle with care — interpretation, synthesis and dissemination of data on paracetamol in pregnancy	102
mTORC1 is the central regulator in pancreatic β-cells	101
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus	101
The interactions between energy homeostasis and neurovascular plasticity	97
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease	95
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity	93
One hundred years of insulin therapy	93
Primary aldosteronism — a multidimensional syndrome	92
Steroid hormones as modulators of anti-tumoural immunity	90
A role for phosphocreatine in adipose inflammation	89
Ketogenic modification of the liver proteome	84
Genetic risk scores improve prediction of obesity in survivors of childhood cancer	83
New role for bone marrow adipocytes in obesity	81
Role of extracellular vesicles in β-cell failure	78
Signals from the dorsal motor nucleus of the vagus promote jejunal fat absorption	77
Urocortin 3 function in glucose metabolism	76
A role for the kidney in metformin action	76
RalA links obesity and mitochondrial dysfunction	75
Progress in islet transplantation is more important than ever	73
The metabolic mythos of ketones	72
GLP1–oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus	71
Advances in basic biology and translation in islet research	67
Stem-cell derived pancreatic endoderm cells in the treatment of T1DM	67
Inflammation-induced adrenal dysfunction	66
Bone and muscle crosstalk in ageing and disease	64
Advances in incretin-based therapeutics for obesity	63
Targeting the incretin system in obesity and type 2 diabetes mellitus	60